Gyn Oncology at Brigham and Women's Hospital
Obstetrics & Gynecology
Dr. Ross S. Berkowitz, MD
|
|
Give Review
Ross Berkowitz is an expert in the field of Obstetrics & Gynecology. He researched medicine at Boston University School of Medicine. Boston University School of Medicine is ranked 30 in research and 52 in primary care medicine He received 6 awards: "America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer", "Meaningful Use Stage 1 Certification", "Fellow (FACOG)" and "Super Doctor". Ross Berkowitz has written publications. He has 101 publications published with PubMed. The lastest paper is: 'Changing Trends in the Clinical Presentation and Management of Complete Hydatidiform Mole Among Brazilian Women.'
Publications
- Changing Trends in the Clinical Presentation and Management of Complete Hydatidiform Mole Among Brazilian Women.
- Optimal management of low-risk gestational trophoblastic neoplasia.
- Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell Carcinoma of the vulva?
- Epithelioid trophoblastic tumor: A single institution case series at the New England Trophoblastic Disease Center.
- Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer.
- Drug-induced death signaling strategy rapidly predicts Cancer response to chemotherapy.
- Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer.
- Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial Carcinoma.
- Protein Kinases and Associated Pathways in Pluripotent State and Lineage Differentiation.
- Women With a Partial Mole During Their First Pregnancy and Diagnosed Earlier in Gestation Are at Increased Risk of Developing Gestational Trophoblastic Neoplasia.
- Endosalpingiosis as it relates to tubal, Ovarian and serous neoplastic tissues: An immunohistochemical study of tubal and Müllerian antigens.
- Clinical Predictors of Long-Term Survival for Stage IVB Uterine Papillary Serous Carcinoma Confined to the Abdomen.
- A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial Cancer.
- Relationship of margin status and radiation dose to recurrence in post-operative vulvar Carcinoma.
- p-21-Activated Kinase-1, -4 and -6 and Estrogen Receptor Expression Pattern in Normal Placenta and Gestational Trophoblastic Diseases.
- Changes in clinical presentation of postterm chorioCarcinoma at the New England Trophoblastic Disease Center in recent years.
- C-terminal binding protein-2 regulates response of epithelial ovarian Cancer cells to histone deacetylase inhibitors.
- Knockdown of core binding factorβ alters sphingolipid metabolism.
- Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial Cancer.
- Endometriosis-associated ovarian Cancer: a review of pathogenesis.
- Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian Carcinoma.
- Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?
- Current advances in the management of gestational trophoblastic disease.
- Gestational trophoblastic disease: Presentations from the XVIth World Congress on Gestational Trophoblastic Diseases.
- A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia.
- Complete hydatidiform mole in women aged 40 to 49 years.
- Prognostic determinants in patients with uterine and ovarian clear Carcinoma.
- Gynecologic Cancer.
- Current management of gestational trophoblastic neoplasia.
- Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta.
- Cerebral venous sinus thrombosis presenting as cerebral metastasis in a patient with chorioCarcinoma following a non-molar gestation.
- C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian Cancer cells to Taxol and Carboplatin.
- Correlates of the preoperative level of CA125 at presentation of ovarian Cancer.
- Up-regulation of stromal versican expression in advanced stage serous ovarian Cancer.
- Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
- Utility of chromosomal chromogenic in Situ hybridization as an alternative to flow cytometry and cytogenetics in the diagnosis of early partial hydatidiform moles: a v...
- "Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".
- Age related cellular immune response against complete molar pregnancy.
- 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
- Gestational trophoblastic disease. Presentations from the XVth World Congress on gestational trophoblastic diseases.
- Complete hydatidiform mole in women older than age 50.
- The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center.
- A gene signature predictive for outcome in advanced ovarian Cancer identifies a survival factor: microfibril-associated glycoprotein 2.
- Clinical practice. Molar pregnancy.
- Management of gestational trophoblastic neoplasia.
- Current management of gestational trophoblastic diseases.
- RUNX3 protein is overexpressed in human epithelial ovarian Cancer.
- Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
- Robotic versus open radical hysterectomy: a comparative study at a single institution.
- Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian Cancer.
- Immune cell profiling in intraplacental and postmolar chorioCarcinomas.
- Vascularization and expression of angiogenic factors in partial and complete molar pregnancies.
- Antigen-specific T cell immune response detected by skewed T cell receptor usage in normal placenta and complete molar pregnancy.
- The changing role of thoracotomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center.
- Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia.
- Gestational trophoblastic disease: presentations from the XLVTH World Congress on Gestational Trophoblastic Diseases.
- Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
- Overexpression of CEACAM6 in borderline and invasive mucinous Ovarian neoplasms.
- Intraplacental chorioCarcinoma arising in a second trimester placenta with partial hydatidiform mole.
- Classification of ovarian Cancer: a genomic analysis.
- Overexpression of laminin receptor 1 on decidual cells in partial and complete mole.
- Immune cell profiling in normal pregnancy, partial and complete molar pregnancy.
- Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian Cancer risk reduction.
- Presence of talc in pelvic lymph nodes of a woman with ovarian Cancer and long-term genital exposure to cosmetic talc.
- Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell Carcinoma.
- Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage ser...
- Fertility-sparing surgery for persistent gestational trophoblastic neoplasia in the myometrium: a case report.
- Gestational trophoblastic disease.
- Intraepithelial Carcinoma of the fimbria and pelvic serous Carcinoma: Evidence for a causal relationship.
- Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenoCarcinomas of different organs.
- Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
- Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal Carcinoma.
- Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
- 25 years' experience in the treatment of gestational trophoblastic neoplasia in Hungary.
- Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
- Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB Cervical cancer.
- Selenium binding protein 1 in ovarian Cancer.
- PTEN expression in clear cell adenoCarcinoma of the ovary.
- Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
- Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.
- Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian Cancer in urine.
- Comparison of osteopontin expression in endometrioid endometrial Cancer and ovarian endometrioid Cancer.
- Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal Carcinomas.
- The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.
- Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenoCarcinomas by cDNA microarray analyses.
- Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
- Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian Cancer.
- Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian Cancer and shows promise as a serum marker.
- Identification of DNA copy number changes in microdissected serous ovarian Cancer tissue using a cDNA microarray platform.
- The role of repeat Uterine evacuation in the management of persistent gestational trophoblastic disease.
- Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
- Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole.
- Predictors of quality of life among long-term survivors of gestational trophoblastic disease.
- Molecular biology of gestational trophoblastic neoplasia: a review.
- Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia.
- Osteopontin as an adjunct to CA125 in detecting recurrent ovarian Cancer.
- Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian Cancer.
- Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors.
- Haptoglobin-alpha subunit as potential serum biomarker in ovarian Cancer: identification and characterization using proteomic profiling and mass spectrometry.
- Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian Cancer cells.
Schools
Boston University School Of Medicine
Peter Bent Brigham Hospital
Boston Hospital Women
Procedures Preformed
- Colporrhaphy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- EndoCervical Curettage
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- Chronic Pelvic Pain
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Meaningful Use Stage 1 Certification
- Fellow (FACOG)
- Super Doctor
Education
-
Brigham and Women's Hospital -
Boston University School of Medicine
Hospital
-
Massachusetts General Hospital -
Newton-Wellesley Hospital -
Dana-Farber Cancer Institute -
Brigham and Women's Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093772782 |
| Last Name Of The Provider | BERKOWITZ |
| First Name Of The Provider | ROSS |
| View All |
Similar Doctors
|
|
Dr. John H. Derry, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth A. Konig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marna B. Dolinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monica M. McKinnon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jan L. Shifren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine Economos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cara A. Attanucci, MD
This Doctor is OpenDoctor Recommended.
|